Cargando…
Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability
Quetiapine fumarate is an antipsychotic drug with poor oral bioavailability (9%) due to first-pass metabolism. Present work is an attempt to improve oral bioavailability of quetiapine fumarate by incorporating in solid lipid nanoparticles (SLN). Six quetiapine fumarate SLN formulations were develope...
Autores principales: | Narala, Arjun, Veerabrahma, Kishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590790/ https://www.ncbi.nlm.nih.gov/pubmed/26555970 http://dx.doi.org/10.1155/2013/265741 |
Ejemplares similares
-
Quality by Design Approach for Development and Characterisation of
Solid Lipid Nanoparticles of Quetiapine Fumarate
por: Agarwal, Shweta, et al.
Publicado: (2020) -
Central Composite Optimization of Glycerosomes for the Enhanced Oral Bioavailability and Brain Delivery of Quetiapine Fumarate
por: Zaki, Randa Mohammed, et al.
Publicado: (2022) -
Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene
por: Patel, B. Divyakant, et al.
Publicado: (2012) -
Oral bioavailability of cantharidin-loaded solid lipid nanoparticles
por: Dang, Yun-Jie, et al.
Publicado: (2013) -
Solid lipid nanoparticles with enteric coating for improving stability, palatability, and oral bioavailability of enrofloxacin
por: Li, Chao, et al.
Publicado: (2019)